Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Neoantigen-based Melanoma-Poly-ICLC Vaccine

Known as: NeoVax Melanoma Vaccine 
A peptide-based melanoma cancer vaccine consisting of neoantigens and peptides derived from patient-specific melanoma immunogenic epitopes, combined… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Glioblastoma, the most common aggressive cancer, has a poor prognosis. Among the current standard treatment strategies, radiation… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 4
Is this relevant?
2019
2019
Background Peptide vaccines offer the opportunity to elicit glioma-specific T cells with tumor killing ability. Using antigens… Expand
  • table 1
  • table 2
Is this relevant?
2019
2019
Immunotherapy, including therapeutic vaccines, is increasingly being developed for patients with high-grade glioma, and… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2012
2012
Background MUC1 is aberrantly expressed in a hypoglycosylated form with lack of luminal polarity in variety of human… Expand
Is this relevant?